DEF 14A
EMERGENT BIOSOLUTIONS INC.
- Company
- Emergent BioSolutions Inc.
- Filed
- April 3, 2009
- Period of Report
- May 21, 2009
- Accession Number
- 0000950133-09-001009
A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →